Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

SELL
$226.52 - $324.64 $1.64 Million - $2.36 Million
-7,260 Reduced 18.4%
32,190 $10.5 Million
Q4 2022

Feb 09, 2023

BUY
$164.02 - $259.76 $1.04 Million - $1.64 Million
6,330 Added 19.11%
39,450 $9.93 Million
Q3 2022

Nov 15, 2022

SELL
$170.68 - $226.46 $128,010 - $169,845
-750 Reduced 2.21%
33,120 $5.87 Million
Q2 2022

Aug 16, 2022

BUY
$147.53 - $266.6 $653,557 - $1.18 Million
4,430 Added 15.05%
33,870 $6.19 Million
Q1 2022

May 16, 2022

BUY
$193.94 - $261.91 $5.71 Million - $7.71 Million
29,440 New
29,440 $7.56 Million
Q1 2021

May 14, 2021

SELL
$182.45 - $249.25 $1.69 Million - $2.3 Million
-9,238 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$119.35 - $200.46 $5.85 Million - $9.82 Million
-49,008 Reduced 84.14%
9,238 $1.74 Million
Q3 2020

Nov 16, 2020

SELL
$87.5 - $130.91 $3.07 Million - $4.59 Million
-35,032 Reduced 37.56%
58,246 $7.52 Million
Q2 2020

Aug 14, 2020

SELL
$49.5 - $97.93 $936,045 - $1.85 Million
-18,910 Reduced 16.86%
93,278 $8.12 Million
Q1 2020

May 13, 2020

SELL
$41.62 - $89.92 $778,710 - $1.68 Million
-18,710 Reduced 14.29%
112,188 $6.76 Million
Q4 2019

Feb 14, 2020

SELL
$52.12 - $75.0 $2.69 Million - $3.87 Million
-51,653 Reduced 28.3%
130,898 $9.71 Million
Q3 2019

Nov 15, 2019

BUY
$61.02 - $70.19 $12,204 - $14,038
200 Added 0.11%
182,551 $11.1 Million
Q2 2019

Aug 13, 2019

BUY
$47.07 - $60.71 $2.93 Million - $3.78 Million
62,268 Added 51.85%
182,351 $11.1 Million
Q1 2019

May 14, 2019

SELL
$39.48 - $62.0 $85,750 - $134,664
-2,172 Reduced 1.78%
120,083 $6.82 Million
Q4 2018

Feb 12, 2019

BUY
$37.07 - $52.58 $4.53 Million - $6.43 Million
122,255 New
122,255 $5.17 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.34B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.